Brainsway

BrainsWay Secures Major Insurance Coverage Expansions for Deep TMS Therapy in Adolescent Depression

- Premera Blue Cross Blue Shield becomes the first payer to formally adopt coverage for BrainsWay's accelerated SWIFT Deep TMS protocol for patients ages 15 and older with moderate to severe major depressive disorder. - Optum Behavioral Health expands its medical policy to cover Deep TMS therapy for adolescents aged 15 and older, representing more than 48 million covered lives in one of BrainsWay's most significant single-policy expansions. - The coverage expansions collectively bring BrainsWay's total covered lives to approximately 180 million across multiple major insurers, addressing an estimated 5 million adolescents aged 15-21 affected by major depression in the United States. - BrainsWay shares gained 10.1% following the Optum announcement, with the stock climbing 53.6% over the past six months as payer confidence in non-drug neurostimulation treatments continues to grow.